|View printer-friendly version|
|February 14, 2002 4:11 p.m.|
|Israel Makov Appointed Teva's Next President and CEO|
Jerusalem, Israel, February 14, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the company's Board of Directors has appointed Mr. Israel Makov to be the company's next President and Chief Executive Officer. Mr. Makov will begin his term upon Eli Hurvitz's retirement from the office after Teva's Annual General Shareholder Meeting, scheduled for April 22nd 2002.